Tecnimede Group
Carla Rosa has had two main work experiences. From 2008 to 2014, they worked at BIAL as a Senior Medicinal Chemist, where they were highly involved in the proposal and creation of new chemical entities for biological targets in CNS diseases. Their responsibilities included drug design, purification, isolation of NCE, and analysis of in vitro and in vivo pharmacological results. Carla also worked on problem-solving, lead optimization, and delivery of the drug candidate. Since 2014, Carla has been working at Grupo Tecnimede as the Head of Chemistry. The specific details of their role at this company are not provided.
Carla Rosa completed their education in a chronological manner. Carla started their academic journey in 2003 at Oxford University, where they pursued a Doctor of Philosophy (PhD) degree in Organic Chemistry, specifically focusing on total synthesis. Carla remained at Oxford University until 2007, successfully completing their PhD.
In 2005, Carla took the opportunity to visit the University of California, Berkeley as a visiting student, further enhancing their knowledge and experience in total synthesis. It is unclear how long they stayed at Berkeley, but it was only for a limited duration within that year.
Lastly, Carla's education history includes a mention of FCT UNL, although specific details such as start and end years, degree name, and field of study are not provided.
This person is not in any teams
Tecnimede Group
1 followers
TECNIMEDE GROUP is composed by pharmaceutical companies of private and 100% Portuguese capital. Started its activity in 1980 and covers the entire life cycle of the medicinal products for human use: development, manufacture, promotion and marketing. TECNIMEDE GROUP's strategy is based on a strong investment in Research, Development and Production of Medicinal Products. It is intended that the results obtained allow to consolidate the Group's position in the Portuguese market and to strengthen exports and internationalization. Atlantic Pharma Brasil and Atlas Pharm (Morocco) are an example of the Group's expansion and development of manufacturing plants. The TECNIMEDE GROUP’s commercial activity is based on: - The solid positioning of the three commercial lines in Portugal; - The direct presence in Spain, Italy, Morocco, Colombia and Brazil; - The establishment of local partnerships in the more than 40 countries where it exports — almost all the European Union countries, as well as several countries in Africa, South America, North America, Asia and the Middle East. TECNIMEDE GROUP's portfolio includes more than 100 products, as a result of its R&D center, which results in more than 2,500 MAs worldwide. Our Mission is the "Improvement and preservation of human life and health through the development, production and marketing of pharmaceutical products with a strong focus on quality and technological innovation.